Skip to main content
FinSpry Logo
FinSpry
ALLO logo
ALLO
(NASDAQ)
Allogene Therapeutics, Inc.
$2.48-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Allogene Therapeutics, Inc. (ALLO) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Allogene Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 8 professional research analysts

Consensus Rating

Buy
Based on 8 unique analysts
(9 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$8.25
↑ 232.66% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest ALLO Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

John Newman
Canaccord Genuity
Strong BuyMaintains
$14.00 → $14.00
Biren Amin
Piper Sandler
BuyMaintains
$7.00 → $8.00
Asthika Goonewardene
Truist
BuyMaintains
$10.00
Matthew Biegler
Oppenheimer
BuyReiterates
$7.00
Luca Issi
RBC Capital
BuyReiterates
$9.00
Reni Benjamin
Citizens
BuyUpgrades
$5.00
Reni Benjamin
Citizens JMP
BuyDowngrades
$5.00
Michael Yee
UBS
Strong BuyInitiates
$8.00
Michael Yee
UBS
BuyInitiates
$8.00

Frequently Asked Questions

What is the analyst consensus rating for ALLO?

The analyst consensus rating for ALLO is "Buy" based on 8 analyst recommendations.

What is the average price target for ALLO?

The average 12-month price target for ALLO is $8.25, representing an upside of 232.7% from the current price of $2.48.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.